Welcome to Bioscan
Extract from the officiel SABC publication (Swiss-American Business Council):
“BioScan, a leading developer in advanced medical imaging
system... can substantially improve the early detection of
cancer… in some cases as much as a year.”
“The new device is capable of detecting cancer at an even earlier
stage than standard commercially available mammography equipment. This
revolutionary, high-resolution real-time x-ray technology, which
results from years of advanced research and development, allows medical
experts to see micro-calcifications as small as 20 microns, the size of
early cancerous cell.
Today’s standard resolution for mammography is 100 microns, but a
growing number of independent studies are showing that increasing
resolution to 50 microns or better can substantially improve the
detection of cancer, in some cases as much as a year earlier than using
100 micron resolution.
BioScan’s research and development in mammography is the result
of ongoing refinements to its core detection and imaging technologies,
which already include two highly advanced systems: IRIS for radiotherapy applications and PIXRAY for radiology:
IRIS is the first real-time (3-10 images per second) digital dynamic imaging system for radiotherapy.
It provides the ability to accurately monitor a patient's position and organ movement during treatment in radio-oncology.
PIXRAY is a new generation film-less X-ray
system. Applications include radioscopy, angiography, hand surgery,
craniofacial surgery, radiography and others. PIXRAY’s innovation
includes its high resolution capabilities...The flat panel X-ray
detector is easily integrated into standard X-ray radiography equipment
for acquisition of real-time images with significant dose reduction
(100 fold) contrast resolution in comparison with standard film
BioScan SA is an operational technology
development company established in Geneva by Professor Zlatko
Dimcovski since 1990.
The company has developed and patented
new types of scanners for cancer treatment and radiological
applications. Its current focus is on the medical field
in both radiography and radiotherapy, and on industrial
applications for non-destructive testing (NDT).
BioScan has successfully
demonstrated and tested its innovative technology in the
extended medical and radiology equipment markets, and
is now entering the industrial non destructive testing
(NDT) market, with new solutions to customers' problems.
What the experts say :
A precision increase in our daily work in the Hospital
Lyon-Sud should make it possible to cure 5% more patients
for ENT, chest, abdomen or pelvis cancers. This means,
in a service such as that of Lyon-Sud, excluding breast
cancer : 900 annual radiations – 40% recovery, 360
patients/year. 5% more means approx. 20 additional recoveries
Pr. JP Gérard
Head of Radiotherapy-Oncology Dept.
Centre Hospitalier Lyon-Sud, France
the new century
Professor Zlatko Dimcovski
worked alongside 6 to be Nobel prize winners when
he worked at CERN (European Organization for Nuclear
Research) , the institution which invented the world
wide web. Then along with co-founder Georges Charpak,
1992 Nobel Prize winner for Physics, set out in 1990
to form Bioscan SA a company who's patented inventions
could help save lives particularly in the areas of
cancer and Parkinson's disease.